Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation Controversies and Advances 2018

LAA Closure: A First Line Option

Presenter: Brian Whisenant

November 16, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

Todd Neale

April 03, 2018

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation Scripps 2016

Putting It All Together: Warfarin, NOAC or LAA Closure?

Presenter: Brian K. Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

Presenter: Brian K. Whisenant

February 03, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation TCT 2014

WaveCrest

Presenter: Reda Ibrahim, Horst Sievert, Maurice Buchbinder, Brian K. Whisenant

September 16, 2014

Presentation TCT 2014

Challenging Case Presentation: Complex LAA Closure Due to Difficult Anatomy

Presenter: Ted E. Feldman, Saibal Kar, Zoltan G. Turi, Brian K. Whisenant

September 16, 2014

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Presentation TCT 2014

Techniques, Results, and Lessons from Surgical LAA Closure

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Subhasis Chatterjee

September 15, 2014

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Presentation TCT 2014

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

Presenter: Samir R. Kapadia, Saibal Kar, Ramon Quesada, Brian K. Whisenant

September 15, 2014

Presentation TCT 2013

For Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Coherex

Presenter: Brian Whisenant

October 27, 2013

Presentation TVT 2013

Review of Risk Scores and How They Guide Therapy

Presenter: Brian Whisenant

June 15, 2013

Advertisement

LAA Closure: A First Line Option

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Putting It All Together: Warfarin, NOAC or LAA Closure?

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

WaveCrest

Challenging Case Presentation: Complex LAA Closure Due to Difficult Anatomy

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Techniques, Results, and Lessons from Surgical LAA Closure

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

For Left Atrial Appendage Occlusion

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Coherex

Review of Risk Scores and How They Guide Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content